The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016–2018: The Ohio Population-Based ALS Registry

Publication
Affiliates	Angeline S. Andrew [1], Erik P. Pioro [2], Meifang Li [3], Xun Shi [3], Jiang Gui [4], Elijah W. Stommel [1], Tanya H. Butt [1], Daniel Peipert [1],Patricia Henegan [1], Maeve Tischbein [1], Pamela Cazzolli [5] John Novak [6], Adam Quick [7], K. Doug Pugar [8], Komal Sawlani [9], Bashar Katirji [9], Todd A. Hayes [10], D. Kevin Horton [11], Paul Mehta [11], Walter G. Bradley [12] [1] Department of Neurology, Geisel School of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA; [2] Section of ALS and Related Disorders, Cleveland Clinic [3] Department of Geography, Dartmouth College [4] Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth [5] ALS Care Project [6] Ohio Health Physician Group [7] Department of Neurology, Ohio State University Wexner Medical Center [8] Dayton Center for Neurological Disorders [9] Department of Neurology, University Hospital Cleveland Medical Center [10] Riverhills Neuroscience [11] Centers for Disease Control and Prevention (CDC), Agency for Toxic Substances and Disease Registry (ATSDR) [12] Department of Neurology, Miller School of Medicine, University of Miami
Journal	Neuroepidemiology
Summary	This study reports the incidence of ALS in Ohio residents diagnosed from October 2016 through September 2018. The Ohio estimated ALS incidence rates were comparable to other state reports in the US; however, there was geospatial variation of incidence estimates that require future investigation.
Link to paper	Find the paper hereexternal icon!

Page last reviewed: November 18, 2021

Content source: Agency for Toxic Substances and Disease Registry